These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 3877181)
21. [125I] 3-quinuclidinyl 4-iodobenzilate: a high affinity, high specific activity radioligand for the M1 and M2-acetylcholine receptors. Gibson RE; Rzeszotarski WJ; Jagoda EM; Francis BE; Reba RC; Eckelman WC Life Sci; 1984 Jun; 34(23):2287-96. PubMed ID: 6727565 [TBL] [Abstract][Full Text] [Related]
22. [Benzodiazepine receptor and cerebral blood flow in early Alzheimer's disease--SPECT study using 123I-iomazenil and 123I-IMP]. Kitamura S; Koshi Y; Komiyama T; Sakayori O; Komaba Y; Ohyama M; Mishina M; Tsuganesawa T; Terashi A Kaku Igaku; 1996 Jan; 33(1):49-56. PubMed ID: 8819714 [TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic simulations of SPECT quantitation of the M2 muscarinic neuroreceptor subtype in disease states using radioiodinated (R,R)-4IQNB. Zeeberg BR; Kim HJ; Reba RC Life Sci; 1992; 51(9):661-70. PubMed ID: 1501511 [TBL] [Abstract][Full Text] [Related]
24. Concerning the distribution of cerebral muscarinic acetylcholine receptors in Alzheimer's disease. Zeeberg B Arch Neurol; 1991 Nov; 48(11):1117-8. PubMed ID: 1953390 [No Abstract] [Full Text] [Related]
25. Synthesis and biodistribution of iodine-125-labeled 1-azabicyclo[2.2.2]oct-3-yl alpha-hydroxy-alpha-(1-iodo-1-propen-3-yl)-alpha-phenylacetate. A new ligand for the potential imaging of muscarinic receptors by single photon emission computed tomography. McPherson DW; DeHaven-Hudkins DL; Callahan AP; Knapp FF J Med Chem; 1993 Apr; 36(7):848-54. PubMed ID: 8464039 [TBL] [Abstract][Full Text] [Related]
26. A comparison of FDG PET and IQNB SPECT in normal subjects and in patients with dementia. Weinberger DR; Jones D; Reba RC; Mann U; Coppola R; Gibson R; Gorey J; Braun A; Chase TN J Neuropsychiatry Clin Neurosci; 1992; 4(3):239-48. PubMed ID: 1498576 [TBL] [Abstract][Full Text] [Related]
32. An assessment of the role of 123I-N-isopropyl-p-iodoamphetamine with single-photon emission computed tomography in the diagnosis of stroke and Alzheimer's disease. Killen AR; Oster G; Colditz GA Nucl Med Commun; 1989 Apr; 10(4):271-84. PubMed ID: 2662071 [TBL] [Abstract][Full Text] [Related]
33. [3H]QNB displays in vivo selectivity for the m2 subtype. Gitler MS; De la Cruz R; Zeeberg BR; Reba RC Life Sci; 1994; 55(19):1493-508. PubMed ID: 7968217 [TBL] [Abstract][Full Text] [Related]
34. [Three-dimensional surface display with 123I-IMP brain perfusion imaging in patients with dementia]. Tomino Y; Tachibana H; Sugita M Rinsho Shinkeigaku; 1994 Apr; 34(4):318-25. PubMed ID: 8026123 [TBL] [Abstract][Full Text] [Related]
35. A randomised placebo controlled study to assess the effects of cholinergic treatment on muscarinic receptors in Alzheimer's disease. Kemp PM; Holmes C; Hoffmann S; Wilkinson S; Zivanovic M; Thom J; Bolt L; Fleming J; Wilkinson DG J Neurol Neurosurg Psychiatry; 2003 Nov; 74(11):1567-70. PubMed ID: 14617718 [TBL] [Abstract][Full Text] [Related]
36. Variability of cerebral blood flow defects in Alzheimer's disease on 123iodo-isopropyl-amphetamine and single photon emission tomography. Derouesne C; Rancurel G; Le Poncin Lafitte M; Rapin JR; Lassen MA Lancet; 1985 Jun; 1(8440):1282. PubMed ID: 2860485 [No Abstract] [Full Text] [Related]